机构地区:[1]广州市第一人民医院康复医学科,510180 [2]广州市第一人民医院中医内科,510180
出 处:《国际医药卫生导报》2021年第12期1778-1781,共4页International Medicine and Health Guidance News
基 金:广东省省级科技计划项目(2017A020213027);广州市名中医工作室建设项目(ky01050002)。
摘 要:目的了解规范的三级康复治疗对缺血性脑卒中患者运动功能障碍恢复的影响。方法选取2018年1月1日至2020年6月30日在本院治疗的缺血性脑卒中患者156例,简单随机分为两组,各78例。对照组男48例,女30例,年龄(66.46±9.79)岁;治疗组男47例,女31例,年龄(65.78±8.91)岁。对照组采用内科常规对症支持治疗,治疗组在对照组基础上进行三级康复治疗(病房床前早期康复介入治疗+康复理疗科继续康复治疗+家庭或社区长时间持续康复治疗)。对患者分别在入组时(M0)及发病1个月后(M1)、3个月后(M3)及6个月后(M6)进行简化Fugl-Meyer运动功能评定量表(Fugl-Meyer Assessment,FMA)评分并记录数据,再对上述数据进行统计学分析。结果M0、M1时,两组缺血性脑卒中患者上肢FMA评分比较,差异均无统计学意义(均P>0.05);M3、M6时,治疗组上肢FMA评分分别为(35.21±20.43)分、(46.67±18.61)分,均高于对照组(24.54±19.52)分、(29.56±21.78)分,差异均有统计学意义(均P<0.05)。M0时,两组缺血性脑卒中患者下肢FMA评分比较,差异无统计学意义(P>0.05);M1、M3、M6时,治疗组下肢FMA评分分别为(18.34±9.67)分、(25.24±9.82)分、(30.51±6.23)分,均高于对照组(13.41±8.72)分、(17.19±8.78)分、(19.65±11.52)分,差异均有统计学意义(均P<0.05)。结论规范的三级康复治疗对改善缺血性脑卒中后运动功能障碍具有明显疗效。Objective To investigate the effect of standardized three-level rehabilitation treatment on motor dysfunction recovery in ischemic stroke patients.Methods A total of 156 ischemic stroke patients who were treated in our hospital from January 1,2018 to June 30,2020 were selected and were simply randomly divided into two groups,78 cases in each group.There were 48 males and 30 females in the control group,with the age of(66.46±9.79)years old;there were 47 males and 31 females in the treatment group,with the age of(65.78±8.91)years old.The control group was given conventional symptomatic and supportive treatment;the treatment group was given three-level rehabilitation treatment on the basis of the control group,including bedside early rehabilitation intervention treatment in the ward,continuous rehabilitation treatment in department of rehabilitation physiotherapy,and long-time continuous rehabilitation treatment in family or community.The simplified Fugl-Meyer Assessment(FMA)scale was scored and recorded for all the patients at the time of enrollment(M0),1 month after the onset(M1),3 months after the onset(M3),and 6 months after the onset(M6),and then the above data were statistically analyzed.Results There were no statistically significant differences in the FMA scores of upper limb between the treatment group and the control group at M0 and M1(both P>0.05);the FMA scores of upper limb in the treatment group at M3 and M6 were(35.21±20.43)points and(46.67±18.61)points,which were higher than those in the control group[(24.54±19.52)points and(29.56±21.78)points](both P<0.05).There was no statistically significant difference in the FMA score of lower limb between the treatment group and the control group at M0(P>0.05);the FMA scores of lower limb in the treatment group at M1,M3,and M6 were(18.34±9.67)points,(25.24±9.82)points,and(30.51±6.23)points,which were higher than those in the control group[(13.41±8.72)points,(17.19±8.78)points,and(19.65±11.52)points](all P<0.05).Conclusion Standardized three-level re
分 类 号:R743.3[医药卫生—神经病学与精神病学] R493[医药卫生—临床医学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...